%0 Journal Article
%T Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study
%A Annette Peters
%A Barbara Thorand
%A Christa Meisinger
%A Christian Herder
%A Cornelia Huth
%A Julia M. Kannenberg
%A Maren Carstensen-Kirberg
%A Michael Roden
%A Wolfgang Koenig
%A Wolfgang Rathmann
%J Archive of "Cardiovascular Diabetology".
%D 2017
%R 10.1186/s12933-017-0498-6
%X Interleukin-22 (IL-22) has beneficial effects on body weight, insulin resistance and inflammation in different mouse models, but its relevance for the development of type 2 diabetes in humans is unknown. We aimed to identify correlates of serum IL-22 levels and to test the hypothesis that higher IL-22 levels are associated with lower diabetes incidence
%K Inflammation
%K Interleukin-22
%K Cytokine
%K Type 2 diabetes
%K Cardiometabolic risk
%K Cohort study
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282888/